Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases.
Morphology of Donor and Recipient Nerves Utilised in Nerve Transfers to Restore Upper Limb Function in Cervical Spinal Cord Injury.
Diagnostic Utility of Systematic Aquaporin-4 Antibodies Determination in the First Event of Immune-Mediated Optic Neuritis.
A Rare Cause of Hemifacial Spasm: Papillary Oncocytic Cystadenoma.
Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS.
Anti-Nogo-A Immunotherapy Does Not Alter Hippocampal Neurogenesis after Stroke in Adult Rats.
Impact of multiple sclerosis on employment and use of job-retention strategies: The situation in France in 2015.
The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
CD27 natural killer cell subsets play different roles during the pre-onset stage of experimental autoimmune encephalomyelitis.
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
The Pharmacokinetics and Dosing of Oral 4-Methylumbelliferone for Inhibition of Hyaluronan Synthesis in Mice.
Investigation of cerebral microbleeds in multiple sclerosis as a potential marker of blood-brain barrier dysfunction.
New Approaches to the Diagnosis, Clinical Course, and Goals of Therapy in Multiple Sclerosis and Related Disorders.
Repetitive element hypermethylation in multiple sclerosis patients.
Depiction of dentatorubrothalamic tract fibers in patients with Parkinson's disease and multiple sclerosis in deep brain stimulation.
[Experience of application of Russian biosimilar of interferon beta-1b for treatment of pediatric multiple sclerosis].
Spinal cord atrophy in neuromyelitis optica spectrum disorders.
IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
Down-regulation of neuronal L1 cell adhesion molecule expression alleviates inflammatory neuronal injury.
Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis.
Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders.
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients.
An emerging role for eotaxins in neurodegenerative disease.
Palliative care in progressive multiple sclerosis.
Adipose stromal vascular fraction-mediated improvements at late-stage disease in a murine model of multiple sclerosis.
Pages
« first
‹ previous
…
797
798
799
800
801
802
803
804
805
…
next ›
last »